Attovia Therapeutics Funding: $60M Raised, Series A (2023)
Attovia Therapeutics is a Biotech company based in Los Altos, California. It has raised $60M in total funding. Latest round: Series A.
Attovia Therapeutics funding overview
Attovia Therapeutics is a Biotech company based in Los Altos, California. Attovia Therapeutics has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in June 2023. The round record for Attovia Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Frazier, venBio, Illumina Ventures, Goldman Sachs Asset Management, Cormorant Asset Management, Nextech Ventures and 4 others. 10 distinct backers are named across the disclosed rounds.
Frequently asked about Attovia Therapeutics funding
How much has Attovia Therapeutics raised?
Attovia Therapeutics has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Attovia Therapeutics?
Frazier, venBio, Illumina Ventures, Goldman Sachs Asset Management, Cormorant Asset Management, Nextech Ventures are named among the investors backing Attovia Therapeutics.
What was the latest Attovia Therapeutics funding round?
The most recent disclosed round is a Series A, announced in June 2023.
Where is Attovia Therapeutics based?
Attovia Therapeutics is based in Los Altos, California.
What sector does Attovia Therapeutics operate in?
Attovia Therapeutics is tracked under Biotech from Los Altos, California, with $60M in disclosed funding.
When did Attovia Therapeutics last raise?
The last disclosed Attovia Therapeutics round closed in June 2023 at Series A.
We update the Attovia Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in Los Altos and their backers are listed below.
